Ventricular Assist Devices (VAD). Extracorporeal Oxygenation and Coronavirus Disease. Surfactant


“Extracorporeal Oxygenation and Coronavirus Disease 2019 Epidemic: Is the Membrane Fail-Safe to Cross Contamination?” – Tammy Sparacino Journal Club.

Surfactant – John Ingram Knowledge Nuggets.

Venovenous extracorporeal membrane oxygenation (ECMO) has been safely used as invasive mechanical respiratory support for almost 40 years. This therapy makes full use of cardiopulmonary bypass (CPB) technologies to take over the respiratory function of the lungs, providing oxygen transport and carbon dioxide removal.

Historically, several factors such as the high-risk profile target population, the complex technical management, and the generalized skepticism affected the widespread adoption of this therapy. Hence, ECMO for refractory respiratory failure became a niche resource limited to small numbers of patients.